6 results
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
in Pulmonary Arterial ... Hypertension (PAH ... #PAH #Management ... #Algorithm #treatment ... #pharmacology
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
Arterial Hypertension ... (PAH) Management ... Algorithm Dr. ... #PAH #Management ... #pharmacology
Chest Pain Diagnosis and Management Algorithm
STEMI:
 - Hx: Pressure like CP, Radiation to arm/jaw, CAD risk
and Management ... Algorithm STEMI: ... Limb ischemia Pulmonary ... Dyspnea, H/O COPD, asthma ... #Management #Algorithm
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
ATRA treatment Pathophysiology ... Release from blast cells ... Imaging: CXR- pulmonary ... (sepsis), PE, DAH ... #management #hematology
Vasculitis - Differential Diagnosis Framework

When to Consider Vasculitis:
• Purpura, ischemic skin lesions
• Mononeuritis multiplex
• Hematuria, proteinuria,
- Differential Diagnosis ... Multinucleated giant cells ... syndrome • Coronary arteries ... Eosinophilia, asthma ... Thrombosis and arterial
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... amyloidosis, PAH ... lubricants • Pharmacologic ... #Management